Feature

New BP guidelines synergize with transformed primary care


 

Systematizing blood pressure management

“Hypertension is a microcosm of the changes that are already happening in U.S. medicine. A lot of what is now going on [in U.S. medicine] is reflected in the guideline,” said Dr. Casey. “Population medicine is now a big deal.”

Dr. Donald E. Casey Jr., chief clinical affairs officer at Medecision in Wayne, Pa. Mitchel L. Zoler/MDedge News

Dr. Donald E. Casey Jr.

Several experts trace the start of systematized U.S. primary care medicine to the advent of patient-centered medical homes, which date to 2007 (JAMA. 2009 May 20;301[19]:2038-40) and rapidly expanded with the quality demands of the Affordable Care Act (Health Aff [Millwood]. 2014 Oct;33[10]:1823-31).

These days, the systematization of U.S. primary care transcends the patient-centered medical home model and appears in several forms. Some of the unifying themes are health care organizations that monitor care through quality metrics, apply quality improvement methods, and provide integrated care through multidisciplinary teams of PCPs, various physician specialists, and an array of nonphysician clinicians, The new ACC/AHA guideline, with its call for new methods of BP measurement, home measurement, lifestyle interventions, team-based care, and use of telemedicine when needed both fits into the patient-centered medical home model and provides an added impetus for primary care medicine to move further down this road.

“The patient-centered medical home has been focused on managing diabetes, so I believe that a patient-centered medical home could be easily designed to deliver better hypertension care,” Dr. Casey noted.

Pages

Recommended Reading

Hypertension guidelines unlikely to hold sway with PCPs
MDedge Endocrinology
Barbershop intervention cuts blood pressure in black men
MDedge Endocrinology
Major message: Most heart failure is preventable
MDedge Endocrinology
VIDEO: Triple-antihypertensive pill nails early therapy
MDedge Endocrinology
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Endocrinology
Consider spironolactone in treatment-resistant hypertension
MDedge Endocrinology
24-hour ambulatory BP measurements strongly predict mortality
MDedge Endocrinology
Women’s representation in CV drug trials still lagging
MDedge Endocrinology
Nebivolol looks like best beta-blocker for hypertension
MDedge Endocrinology
MDedge Daily News: Is ‘medical aid in dying’ suicide?
MDedge Endocrinology

Related Articles